SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062942
Filing Date
2023-11-13
Accepted
2023-11-13 16:10:39
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q grph-20230930.htm   iXBRL 10-Q 2506643
2 EX-10.1 grph-ex10_1.htm EX-10.1 30779
3 EX-10.2 grph-ex10_2.htm EX-10.2 211098
4 EX-31.1 grph-ex31_1.htm EX-31.1 18400
5 EX-32.1 grph-ex32_1.htm EX-32.1 10460
  Complete submission text file 0000950170-23-062942.txt   10261344

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grph-20230930_pre.xml EX-101.PRE 405141
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grph-20230930.xsd EX-101.SCH 68695
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grph-20230930_def.xml EX-101.DEF 254955
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grph-20230930_cal.xml EX-101.CAL 44198
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grph-20230930_lab.xml EX-101.LAB 550259
64 EXTRACTED XBRL INSTANCE DOCUMENT grph-20230930_htm.xml XML 1919209
Mailing Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40532 | Film No.: 231398787
SIC: 2836 Biological Products, (No Diagnostic Substances)